The following research subjects are active
- Analysis of structure - metabolism relationships. - Combinatorial synthesis of Epidermal Growth Factor Receptor (EGFR) inhibitors. - Design and QSAR of endocannabinoid system modulators. - Design, synthesis and QSAR of histamine H3 receptor antagonists. - Design, synthesis and QSAR of melatonin receptor ligands. - Design, synthesis and QSAR of nuclear receptor modulators. - Design, synthesis, structural characterization and SAR/QSAR studies of heterocyclic compounds as potential antimicrobial, antiviral, antiproliferative, anti-inflammatory, antidegenerative on cartilage, antiplatelet, and local anaesthetic agents - Experimental determination of physico-chemical properties of drugs. - New synthetic pathways, through phosphorous compounds, to heterocyclic intermediates useful in the preparation of derivatives of biopharmacological interest - Studies of chemical and metabolic drug and prodrug stability. - Synthesis, chemical and biological evaluation of heterocyclic compounds and phenylureas interesting as potential plants growth regulators